The IRS War on Medical Marijuana Providers

Dispensaries providing marijuana to doctor-approved patients operate in a number of states, but they are under assault by the federal government.

SWAT-style raids by the DEA and finger-wagging press conferences by grim-faced federal prosecutors may garner greater attention, but the assault on medical marijuana providers extends to other branches of the government as well, and moves by the Internal Revenue Service (IRS) to eliminate dispensaries' ability to take standard business deduction are another very painful arrow in the federal quiver.

The IRS employs Section 280E, a 1982 addition to the tax code that was a response to a drug dealer's successful effort to claim his yacht, weapons purchases, and even illicit bribes as business expenses. Under 280E, individuals involved in the illicit sale of controlled substances — including marijuana, even medical marijuana in states where it is legal — cannot claim standard business expenses on their federal taxes.

"The 280E provision which requires certain businesses to pay taxes on their gross income, as opposed to their net income, is aimed at shutting down illicit drug operations, not state-legal medical marijuana dispensaries," said Kris Hermes, spokesman for the medical marijuana defense group Americans for Safe Access." Nonetheless, the Obama Administration is using Section 280E to push these local and state licensed facilities out of business."

The provision can be used to great effect. Oakland's Harborside Health Center was hit with a $2 million IRS assessment in 2011 after the tax agency employed Section 280E against. Harborside is fighting that assessment, even as it continues to try to fend off federal prosecutors' attempts to shut it down by seizing the properties it leases. Similarly, when the feds raided Richard Lee's Oaksterdam University that same year, it wasn't just DEA, but also IRS agents who stormed the premises. Lee said it was because of a 280E-related audit.

The attacks on Harborside and Oaksterdam were part of an IRS campaign of aggressive audits using 280E to deny legitimate business expenses, such as rent, payroll, and all other necessary business expenses. These denials result in astronomical back tax bills for the affected dispensaries, threatening their viability — and patients' access to their medicine.

"Should the IRS campaign be successful; it will throw millions of patients back in to the hands of street dealers; eliminate tens of thousands of well paying jobs, destroy hundreds of millions of dollars of tax revenue; enrich the criminal underground; and endanger the safety of communities in the 17 medical cannabis states," said Harborside's Steve DeAngelo as he announced the 280E Reform Project to begin to fight back.

It's going to be an uphill battle. In the last Congress, Rep. Pete Stark (D-CA) introduced House Bill 1985, the Small Business Tax Equity Act, designed to end the 280E problem for medical marijuana businesses, but it went to the Republican-controlled House Ways and Means Committee, where it was never heard from again.

Still, something needs to happen, said Betty Aldworth, deputy director of the National Cannabis Industry Association, which this year is working with members of Congress to try to find a fix for the 280E problem.

"When Section 280E was created in the 1980s, no one imagined state-legal marijuana providers," Aldworth told the Chronicle. "Whether or not it is part of a larger effort to curtail the development of regulated models for providing marijuana, which is a model that is clearly preferable to leaving this popular and relatively safe medicine (or adult product) in the underground market, these onerous tax rates have severely hampered the development of the regulated market."

It's a brake on the overall economy, Aldworth said.

"Not only has it resulted in stymieing job development, but it also curtails other economic activity such as reinvestment in business and the rippling positive effects of that spending," she argued. "And in many cases, it has created a tax burden that is simply unbearable: many providers have had to close their doors and lay off their staffs because the tax burden was simply too great."

Because of this unintended application of 280E, medical marijuana providers are paying overall taxes at a rate two to three times those of other small businesses, Aldworth said.

"It's important to note that just as they want to apply for licenses, follow regulations, and otherwise participate in the legal business community, state-legal marijuana providers also want to pay their fair share of taxes," she pointed out. "Most small businesses pay an effective tax rate of between 13% and 27% on net income, according to the Small Business Administration. State-legal marijuana providers pay an average effective tax rate of 65-80%. An industry that can provide thousands of jobs is being held back by these crazy tax rates."

While the lobbyists look to Congress for a fix, one academic tax law expert thinks he has hit upon a novel solution, but not everyone agrees.

Benjamin Leff, a professor at American University's Washington College of Law, raised eyebrows at a Harvard University seminar this spring when he presented his report,Tax Planning For Marijuana Dealers, where he suggested that dispensaries get around 280E by registering with the IRS as tax-exempt social welfare organizations, known as 501(c)(3)s or 501(c)(4)s.

The IRS has already ruled that medical marijuana providers can be exempt under 501(c)(3) because its "public policy doctrine" does not allow charitable organizations to have purposes contrary to law, but in the paper, Leff argued that "a state-sanctioned marijuana seller could qualify as tax-exempt under 501(c)(4), since the public policy doctrine only applies to charities, and 501(c)(4) organizations are not charities."

The organization would have to be operated to improve the social and economic conditions of a neighborhood blighted by crime or poverty, by providing job training, employment opportunities, and improved business conditions for commercial development in the neighborhood, just like many existing community economic development corporations that run businesses.

"When taxes get too high, you can drive compliant dispensaries out of business," Leff told the Chronicle.

Americans for Safe Access' Hermes would agree with that, but he's not so sure about Leff's idea.

"The concept of medical marijuana dispensaries registering with the federal government as a 501(c)(4) in order to sidestep section 280E is novel and may be hypothetically valid," he said. "However, the IRS will refuse to grant tax-exempt status to a business that the agency believes is violating federal law. Perhaps, it would be possible for a dispensary to obtain 501(c)(4) status under false pretenses, but such status would not very likely withstand an IRS audit."

There are better ways, he said.

"A much more realistic and sensible approach — pending a change to the federal classification of marijuana for medical use — is to amend the tax code to exclude state-lawful medical marijuana businesses from Section 280E," Hermes recommended. "This is the kind of legislation that Congress should pass in order to allow states to implement their own medical marijuana laws, without undue interference by the federal government."

"I agree with everything he said," Leff replied. "But it's not just the Obama administration that is using 280E this way. The Supreme Court has held that there is no exception to the Controlled Substances Act for state-level legal marijuana sales, and since 280E makes references to Schedule I controlled substances, it applies to legal marijuana unless Congress changes the law. I totally agree that Congress should amend 280E to exempt marijuana selling that is legal under state law. Congress could also amend the Controlled Substances Act to remove marijuana from it, which would probably also make sense," he added.

Whether it is by act of Congress, internal policy shifts, or creative thinking by law school professors, some way has to be found to exempt state-permitted medical marijuana providers from the clutches of 280E and its punitive tax burden aimed at dope dealers, or there may not be any medical marijuana providers.

– Article originally from Stop the Drug War, used with permission.



  1. gstlab3 on

    power corrupts and absollute power corrupts absollutley.,

    the U.S. government is corrupted top to bottom.

  2. Mrs. RatsRectum on

    Is it possible for a 501c(4) to be structured so that some or all of its contributors, who are allowed to remain anonymous, can to get the feds to overlook the fact that cannabis is illegal on paper only? Possible to store money there so that if the feds rob the non-profit cannabis clubs via the IRS or DEA that the money could find its way directly or indirectly through a patient or group of patients back to the club to keep it running or get it back up and running again? Any chance the O’Bummer administration will issue a memorandum excluding cannabis as one of the reasons NOT to issue an organization tax-free status? Legislative adjustment to the current law making the federal prohibition of cannabis moot in granting tax-free status?

  3. robertbertrandgriffith on

    Sent: Tuesday, May 7, 2013 4:33 AM
    Subject: Sex Superbug, Lab 257 Book, Lyme Disease, Unlawful Cannabis – Prosecute Treason Now!

    Attorney General Holder Says One Thing While His U.S. Attorneys Do Another
    Sent: Wednesday, May 15, 2013 1:33 AM
    Subject: ‘Lyme Rage’ ABC News : Great Pur·pose Con·t?a·gious In·ten·tion : Purge Pro·mot·ers
    Sent: Tuesday, May 14, 2013 8:33 PM
    Link cannabinoid anandamide inhibits human breast cancer cell proliferation
    Posted by Anonymous on Mar 21 2012
    Night Terrors Make Sleeping Kids Scream
    The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
    Anandamide was the first brain metabolite shown to act as a ligand of “central” CB1 cannabinoid receptors. Here we report that the endogenous cannabinoid potently and selectively inhibits the proliferation of human breast cancer cells in vitro. Tuesday, November 20, 2012 4:44 AM Saturday, December 1, 2012 9:11 PM
    Subject: ‘Lyme Rage’: Can Lyme Disease Affect Your Personality? Cannabis plant extracts can effectively fight drug-resistant bacteria.
    Cannabis plant extracts can effectively fight drug-resistant bacteria.
    ‘Lyme Rage’: Can Lyme Disease Affect Your Personality?–nfl.htmlSent: Friday, November 30, 2012 7:33 AM
    Subject: Business News Media Sell Out aid and abets IRS Assault for Death Cost Paid by Citizens who will not fight!Subject: Hor·rif·ic Death Highest Costs – Weed Lyme Crime – see Plum Island Conspiracy & movie “Under Our Skin”
    Subject: Seeing is Believing MRI Pictures Cannabis Cures Baby Brain HuffPo Video Courtney thinks the cancer-fighting molecules in pot – which are non-toxic and have little to no side effects – should be “frontline therapy” for horrific brain tumors that would normally require radiation and chemotherapy, which have very, very serious side effects that include creating new cancer.
    Subject: Just Wrath Required for Hedging Necessary Collections : Weed Lyme Crime!
    Attorney General Holder Says One Thing While His U.S. Attorneys Do AnotherSent: Tuesday, May 14, 2013 5:33 AM
    Subject: Super News Mosquitoes Carry Lyme Disease Obamacare IRS Assault Kudlow Report
    Proc Natl Acad Sci U S A. 1998 July 7; 95(14): 8375–8380.
    PMCID: PMC20983
    The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
    Luciano De Petrocellis,*† Dominique Melck,*‡ Antonella Palmisano,§ Tiziana Bisogno,‡ Chiara Laezza,¶ Maurizio Bifulco,¶ and Vincenzo Di Marzo‡?
    †Istituto di Cibernetica and ‡Istituto per la Chimica di Molecole di Interesse Biologico (affiliated with the National Institute for the Chemistry of Biological Systems, Consiglio Nazionale delle Ricerche), Consiglio Nazionale delle Ricerche, Via Toiano 6, 80072 Arco Felice, Naples, Italy; § Istituto di Ricerche sull’Adattamento dei Bovini e dei Bufali all’Ambiente del Mezzogiorno, Consiglio Nazionale delle Ricerche, Ponticelli, 80147 Naples, Italy; and ¶Centro di Studio der l’Endocrinologia e l’Oncologia Sperimentale, Consiglio Nazionale Delle Richerche and Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli ‘Federico II,’ 80131 Naples, Italy*L.D.P. & D.M. contributed equally to this work.?To whom reprint requests should be addressed. e-mail: [email protected] .Communicated by Rita Levi-Montalcini, Institute of Neurobiology, Consiglio Nazionale delle Ricerche, Rome, Italy
    Author information ? Article notes ? Copyright and License information ?Received March 6, 1998; Accepted April 29, 1998.
    Copyright © 1998, The National Academy of Sciences
    This article has been cited by other articles in PMC.
    Go to: